Suppr超能文献

海洋放线菌中的生物活性化合物。

Bioactive compounds from marine actinomycetes.

机构信息

Acharya Narendra Dev College, University of Delhi, Govindpuri, Kalkaji, New Delhi, 110 019 India.

出版信息

Indian J Microbiol. 2008 Dec;48(4):410-31. doi: 10.1007/s12088-008-0052-z. Epub 2009 Jan 8.

Abstract

Actinomycetes are one of the most efficient groups of secondary metabolite producers and are very important from an industrial point of view. Among its various genera, Streptomyces, Saccharopolyspora, Amycolatopsis, Micromonospora and Actinoplanes are the major producers of commercially important biomolecules. Several species have been isolated and screened from the soil in the past decades. Consequently the chance of isolating a novel actinomycete strain from a terrestrial habitat, which would produce new biologically active metabolites, has reduced. The most relevant reason for discovering novel secondary metabolites is to circumvent the problem of resistant pathogens, which are no longer susceptible to the currently used drugs. Existence of actinomycetes has been reported in the hitherto untapped marine ecosystem. Marine actinomycetes are efficient producers of new secondary metabolites that show a range of biological activities including antibacterial, antifungal, anticancer, insecticidal and enzyme inhibition. Bioactive compounds from marine actinomycetes possess distinct chemical structures that may form the basis for synthesis of new drugs that could be used to combat resistant pathogens.

摘要

放线菌是次级代谢产物生产效率最高的一类微生物,从工业角度来看具有非常重要的地位。在其各种属中,链霉菌属、糖多孢菌属、拟无枝酸菌属、小单孢菌属和游动放线菌属是具有商业重要性的生物分子的主要生产者。过去几十年已经从土壤中分离和筛选了多种放线菌。因此,从陆地生境中分离出一种能够产生新的生物活性代谢物的新型放线菌菌株的机会已经减少。发现新型次级代谢产物的最相关原因是为了规避对抗生素产生耐药性的病原体的问题,这些病原体对目前使用的药物不再敏感。迄今尚未开发的海洋生态系统中存在放线菌。海洋放线菌是新型次级代谢产物的有效生产者,具有多种生物活性,包括抗菌、抗真菌、抗癌、杀虫和抑制酶活性。海洋放线菌的生物活性化合物具有独特的化学结构,可能为合成新的药物奠定基础,这些药物可用于对抗耐药性病原体。

相似文献

1
Bioactive compounds from marine actinomycetes.海洋放线菌中的生物活性化合物。
Indian J Microbiol. 2008 Dec;48(4):410-31. doi: 10.1007/s12088-008-0052-z. Epub 2009 Jan 8.
2
Marine actinobacteria: an important source of bioactive natural products.海洋放线菌:生物活性天然产物的重要来源。
Environ Toxicol Pharmacol. 2014 Jul;38(1):172-88. doi: 10.1016/j.etap.2014.05.014. Epub 2014 Jun 4.
3
Pharmaceutically active secondary metabolites of marine actinobacteria.海洋放线菌的具有药用活性的次生代谢产物。
Microbiol Res. 2014 Apr;169(4):262-78. doi: 10.1016/j.micres.2013.07.014. Epub 2013 Aug 16.
8
Diversity and Biotechnological Potential of Marine Actinomycetes from India.印度海洋放线菌的多样性及其生物技术潜力
Indian J Microbiol. 2022 Dec;62(4):475-493. doi: 10.1007/s12088-022-01024-x. Epub 2022 May 15.
9
Secondary metabolites and biodiversity of actinomycetes.放线菌的次生代谢产物与生物多样性
J Genet Eng Biotechnol. 2021 May 12;19(1):72. doi: 10.1186/s43141-021-00156-9.

引用本文的文献

8
Anti-Candidal Marine Natural Products: A Review.抗念珠菌海洋天然产物综述
J Fungi (Basel). 2023 Jul 28;9(8):800. doi: 10.3390/jof9080800.
9
Antioxidant and Antidiabetic Activity of Algae.藻类的抗氧化和抗糖尿病活性
Life (Basel). 2023 Feb 7;13(2):460. doi: 10.3390/life13020460.

本文引用的文献

6
Metagenomics, biotechnology with non-culturable microbes.宏基因组学,研究不可培养微生物的生物技术。
Appl Microbiol Biotechnol. 2007 Jul;75(5):955-62. doi: 10.1007/s00253-007-0945-5. Epub 2007 Mar 30.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验